Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS2 Block for Post-sternotomy Pain
NCT04282239Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine, lidocaine and dexmedetomidine in postoperative pain, sponsored by NYU Langone Health. Primary endpoints: Critical-Care Pain Assessment Tool at 24 hours and Visual Analog Scale at 24 hours. Planned start Mar 2021; status: withdrawn.
02
Drugs
ropivacainelidocainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04282239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04282239.